Literature DB >> 29133258

When Should Patients Undergo Genetic Testing for Hereditary Colon Cancer Syndromes?

Gregory Idos1, Samir Gupta2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29133258      PMCID: PMC8283794          DOI: 10.1016/j.cgh.2017.11.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  12 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 2.  Colorectal surveillance in Lynch syndrome families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Heikki J Järvinen; Patrick M Lynch; Christoph Engel; Jukka-Pekka Mecklin; Hans F A Vasen
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

3.  Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Dawn Provenzale; Samir Gupta; Dennis J Ahnen; Travis Bray; Jamie A Cannon; Gregory Cooper; Donald S David; Dayna S Early; Deborah Erwin; James M Ford; Francis M Giardiello; William Grady; Amy L Halverson; Stanley R Hamilton; Heather Hampel; Mohammad K Ismail; Jason B Klapman; David W Larson; Audrey J Lazenby; Patrick M Lynch; Robert J Mayer; Reid M Ness; Scott E Regenbogen; Niloy Jewel Samadder; Moshe Shike; Gideon Steinbach; David Weinberg; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2016-08       Impact factor: 11.908

4.  Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Authors:  Uri Ladabaum; Grace Wang; Jonathan Terdiman; Amie Blanco; Miriam Kuppermann; C Richard Boland; James Ford; Elena Elkin; Kathryn A Phillips
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

5.  Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.

Authors:  Laura C Beamer; Marcia L Grant; Carin R Espenschied; Kathleen R Blazer; Heather L Hampel; Jeffrey N Weitzel; Deborah J MacDonald
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

6.  Identification of Lynch syndrome among patients with colorectal cancer.

Authors:  Leticia Moreira; Francesc Balaguer; Noralane Lindor; Albert de la Chapelle; Heather Hampel; Lauri A Aaltonen; John L Hopper; Loic Le Marchand; Steven Gallinger; Polly A Newcomb; Robert Haile; Stephen N Thibodeau; Shanaka Gunawardena; Mark A Jenkins; Daniel D Buchanan; John D Potter; John A Baron; Dennis J Ahnen; Victor Moreno; Montserrat Andreu; Maurizio Ponz de Leon; Anil K Rustgi; Antoni Castells
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

7.  Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.

Authors:  Shilpa Grover; Elena M Stoffel; Laoti Bussone; Elizabeth Tschoegl; Sapna Syngal
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

8.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Authors:  Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2014-07-22       Impact factor: 10.864

Review 9.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.

Authors:  Glenn E Palomaki; Monica R McClain; Stephanie Melillo; Heather L Hampel; Stephen N Thibodeau
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.